Peanut Allergy Rates in Toddlers Fall by 43 Percent

The rate of peanut allergies among children under the age of three has dropped by approximately 43 percent over the past ten years. This sharp decline, detailed in a study released in October 2025, challenges the long-standing medical advice that parents should delay the introduction of peanut products to young children.

For decades, the standard guidance was to avoid peanuts until a child was older. That advice reversed in recent years. The American Academy of Pediatrics now recommends introducing peanut products to infants between four and six months of age, provided the babies are already eating other solid foods and have no history of prior reactions. Pediatricians advise parents to start with small amounts and feed peanut foods at least twice a week during the first year of life and beyond. To prevent choking, whole peanuts are strictly prohibited for infants.

Dr. David Hill, the lead author of the study, identifies the change in clinical guidance as the primary driver behind the drop in allergy rates. He argues that the new approach has likely prevented thousands of cases that would have occurred under the previous model of delayed exposure. “It’s safe to say in all likelihood, there are tens of thousands of kids today that don’t have food allergy that may have if we hadn’t made these recommendations about early allergen introduction,” Dr. Hill said.

The shift in medical practice has altered daily life for many families. Kristie Herring, a mother whose son Parker suffered from a severe peanut allergy, described the diagnosis as a total surprise, noting that the condition was unexpected given their family medical history. Parker is currently undergoing oral immunotherapy. This treatment involves the slow, controlled increase of peanut protein doses to build tolerance. The process has allowed him to safely consume peanut butter again.

Experts caution that early introduction is not a universal cure. Food allergy is a complex condition with multiple underlying causes, and oral immunotherapy carries its own set of risks. For children who have already developed an allergy, specialists recommend consulting an allergist to explore treatment options and maintain careful management of the condition.

The study highlights a concrete outcome of changing pediatric protocols. By moving from avoidance to early inclusion, the medical community has achieved a measurable reduction in a common childhood allergy. The current recommendation stands for all infants without prior reactions, emphasizing regular intake rather than a one-time trial.